Genmab — September 2020
-
GENMAB A/S GMAB.CO: GUGGENHEIM RAISES PRICE TARGET TO DKK 2684 FROM DKK 2568 - Reuters News
-
ØU er nu meget bullish på casen?
-
Vi fik vist reddet lidt af æren i dag på en uge, der ændrede noget af grundforståelsen af GEN/JJ forholdet. Pensionisten ramte den vist lige bagi med hvad der må være kandidaten til årets citat: “ Katastrofen blev vendt til en møgdag ;-)”
-
Det har du faktisk ret i. Tror dog ikke det er en bevidst handling.
-
NBI +2,18%
-
Efficacy of daratumumab in the treatment of multiple myeloma with high-risk cytogenetics: Meta-analysis of randomized phase III trials https://twitter.com/mtmdphd/status/1309129398990385153?s=21
-
God morgen.
-
Daratumumab (anti-CD38) for treatment of disseminated nontuberculous mycobacteria in a patient with anti-IFN-γ autoantibodies https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa1086/5880009
-
I noted Genmab is looking for an Infectious Diseases Scientist and that there is something called "Genmab Infectious Disease initiative" https://genmab.wd3.myworkdayjobs.com/en-US/Genmab_Careers_Site/job/Utrecht/Scientist--Infectious-Diseases_R414
-
Faldt lidt tilfældigt over denne gamle nyhed, som jeg ikke havde hørt om før: Tavotek Biotherapeutics Announces a Research Agreement with Genmab for the Development of Bispecific Antibodies using Genmab’s Proprietary DuoBody
Technology Platform against a Pair of Disease Relevant Targets
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind